<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF REVIEW: The purpose of this review is to examine the appropriateness of coronary artery bypass grafting (CABG) for the patient with ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>RECENT FINDINGS: CABG is the gold standard therapy for patients with advanced multivessel and left main <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>A critical analysis of the Surgical Treatment of Ischemic <z:hpo ids='HP_0001635'>Heart Failure</z:hpo> (STICH) trial confirms the benefit of CABG for patients with ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>SUMMARY: CABG can be safely applied to patients with <z:hpo ids='HP_0001635'>heart failure</z:hpo> and provides benefit for appropriately selected patients </plain></SENT>
</text></document>